The Government of Saskatchewan announced this week that more patients in Saskatchewan living with cystic fibrosis are now eligible for Trikafta. It is a medication that improves lung function.

This expansion will cover most Saskatchewan patients with CF. The province says according to the Canadian Cystic Fibrosis Registry, there are more than 4,400 CF patients in Canada and more than 130 patients in Saskatchewan.

On November 4, the Canadian Agency for Drugs and Technologies in Health issued a recommendation that jurisdictions expand coverage of Trikafta for patients with 152 rare genetic mutations.

Patients with CF or parents/guardians of children with CF who think they may benefit from therapy with Trikafta are urged to speak with their doctor.